Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age ID6484

  • Awaiting development
  • GID-HST10063
  • Expected publication date: TBC

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6484

Referral

Referral

Topic selection